US FDA gets strict on guidance timelines
This article was originally published in Clinica
Executive Summary
The US FDA has set strict timelines to ensure that medical device guidelines that are currently in draft format are either withdrawn, re-opened for comment or are re-issued as draft guidelines to reflect the agency's current thinking on the topics in question.